Spero Therapeutics(DE:2HA)
€0.92+0.03 (+3.59%)
DE:2HA
Spero Therapeutics Revenue
€0.92
At close:+0.03 (+3.59%)
Spero Therapeutics (2HA) Revenue
2 Followers
Spero Therapeutics Revenue
Spero Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with -100.00%. This bring the company's revenue in the last twelve months to 42.96M, Decreased 21.55%. In the fiscal year ending Dec 31, 2025, Spero Therapeutics had annual revenue of 59.62M with 24.27% growth.
- Revenue (ttm)
- 42.96M
- Revenue Growth
- 18.44%
- P/S Ratio
- 0.89
- Revenue/Employee
- EUR 2,384,760
- Employees
- 25
- Market Cap
- EUR 53.00M
Revenue Chart
Spero Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 59.62M | 11.64M | 24.27% |
| Dec 31, 2024 | 47.98M | -55.80M | -53.77% |
| Dec 31, 2023 | 103.78M | 55.20M | 113.63% |
| Dec 31, 2022 | 48.58M | 45.51M | 1482.38% |
| Mar 31, 2022 | 3.07M | -6.26M | -67.10% |
| Dec 31, 2020 | 9.33M | -8.82M | -48.59% |
| Dec 31, 2019 | 18.15M | 14.18M | 357.56% |
| Dec 31, 2018 | 3.97M | 1.99M | 100.40% |
| Dec 31, 2017 | 1.98M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.